Bharat Immunologicals & Biologicals (BOM:524663) Change In Receivables : ₹0.00 Mil (TTM As of Sep. 2023)

View and export this data going back to 2000. Start your Free Trial

What is Bharat Immunologicals & Biologicals Change In Receivables?

Bharat Immunologicals & Biologicals's change in receivables for the quarter that ended in Sep. 2023 was ₹0.00 Mil. It means Bharat Immunologicals & Biologicals's Accounts Receivable stayed the same from Jun. 2023 to Sep. 2023 .

Bharat Immunologicals & Biologicals's change in receivables for the fiscal year that ended in Mar. 2023 was ₹-127.43 Mil. It means Bharat Immunologicals & Biologicals's Accounts Receivable increased by ₹127.43 Mil from Mar. 2022 to Mar. 2023 .

Bharat Immunologicals & Biologicals's Accounts Receivable for the quarter that ended in Sep. 2023 was ₹100.26 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Bharat Immunologicals & Biologicals's liquidation value for the three months ended in Sep. 2023 was ₹-922.82 Mil.

Bharat Immunologicals & Biologicals Change In Receivables Historical Data

The historical data trend for Bharat Immunologicals & Biologicals's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bharat Immunologicals & Biologicals Change In Receivables Chart

Bharat Immunologicals & Biologicals Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Change In Receivables

Get a 7-Day Free Trial

-570.28

553.58

176.03

-11.23

-127.43

Bharat Immunologicals & Biologicals Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
Change In Receivables	Get a 7-Day Free Trial															-	-	-	-	-

Bharat Immunologicals & Biologicals Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0.00 Mil.

Bharat Immunologicals & Biologicals (BOM:524663) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Bharat Immunologicals & Biologicals's Days Sales Outstanding for the quarter that ended in Sep. 2023 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	100.256	/	0	*	91
=

2. In Ben Graham's calculation of liquidation value, Bharat Immunologicals & Biologicals's accounts receivable are only considered to be worth 75% of book value:

Bharat Immunologicals & Biologicals's liquidation value for the quarter that ended in Sep. 2023 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	89.093	-	1094.226	+	0.75 * 100.256	+	0.5 * 14.24
=	-922.82

Bharat Immunologicals & Biologicals Change In Receivables Related Terms

Thank you for viewing the detailed overview of Bharat Immunologicals & Biologicals's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Bharat Immunologicals & Biologicals (BOM:524663) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Bharat Immunologicals & Biologicals Corp Ltd (BOM:524663) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

N/A

Address

Village Chola, BIBCOL, OPV Plant, Bulandshahar, UP, IND, 203203

Website

http://www.bibcol.sciencecentral.in

Bharat Immunologicals & Biologicals Corp Ltd is an India-based biotechnology company. It primarily manufactures Oral polio vaccines. In addition, the company also manufactures zinc tablets, diarrhea management kits, and Ready to Use Therapeutic Food (RUTF). It also manufactures nutraceuticals and biological products for the treatment of health deficiencies and disorders. The firm is organized into three segments: Oral Polio Vaccine, Zinc Tablets, and BIB VIT, BIBSANIT. The group principally operates in India and generates the majority of its revenue from sales of Oral polio vaccines.

Bharat Immunologicals & Biologicals (BOM:524663) Headlines

No Headlines